Adaptive Biotechnologies Corp (NASDAQ: ADPT) Continues To Thrive In 2025, As Its Stock Is Up 55.30% Year-To-Date
During the last session, Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s traded shares were 1.75 million, with the beta value of the company hitting 1.78. At the end